CLINICAL_TRIALS
ClinicalTrials.gov record update
The Safety and Efficacy of Anti-EBV Autologous TCR-T Cell Injection for Treating Relapsed/Refractory EBV-positive Lymphoma Patients With HLA-A11:01
This page presents selected fields from the linked source record. It does not add a medical interpretation.
Record identity and dates
- Source
- ClinicalTrials.gov
- Source record ID
- NCT07162012
- Title field or adapter rule
- protocolSection.identificationModule.officialTitle
- Ingested At
- 2026-04-25T22:28:54.089302+00:00
- Published At
- 2025-12-02T00:00:00+00:00
- Record Updated At
- 2025-12-02
- Timestamp Basis
- source retrieval time was not retained by the feed adapter
- Date limitation
- source retrieval time was not retained by the feed adapter
Fields recorded by this source
- protocolSection.conditionsModule.conditions
["NK/T-cell Lymphoma", "Peripheral T-cell Lymphoma (PTCL)", "DLBCL"]- protocolSection.statusModule.lastUpdatePostDateStruct.date
"2025-12-02"- protocolSection.identificationModule.nctId
"NCT07162012"- protocolSection.identificationModule.officialTitle
"The Safety and Efficacy of Anti-EBV Autologous TCR-T Cell Injection for Treating Relapsed/Refractory EBV-positive Lymphoma Patients With HLA-A11:01"- protocolSection.statusModule.overallStatus
"RECRUITING"- protocolSection.designModule.phases
["EARLY_PHASE1"]- protocolSection.statusModule.resultsFirstPostDateStruct.date
""
Study condition terms
Intervention details are not present in the imported fields for this record. No drug-condition relationship is inferred from co-listing.
This index keeps the source fields it imported; it may not contain the complete original record. Verify wording and context in the linked source.